Ajax-Loading

Eli Lilly and Company - Total Stockholder Equity

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Stockholder-Equity" stands at 23.85 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Total Stockholder Equity" stands at 23.85 Billion USD. This represents an increase of 29.98 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 66.55 percent compared to the value the year prior.
The 1 year change in percent is 66.55.
The 3 year change in percent is 134.62.
The 5 year change in percent is 377.40.
The 10 year change in percent is 56.49.

The Serie's long term average value is 12.43 Billion United States Dollars. It's latest available value, on 09/30/2025, is 91.84 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2019, to it's latest available value, on 09/30/2025, is +829.86%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Total Stockholder Equity for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Total Stockholder Equity486,508,953,600.00
LogoAbbVie Inc - Total Stockholder Equity399,570,305,024.00
LogoRoche Holding AG - Total Stockholder Equity317,433,206,677.55
LogoAstraZeneca PLC - Total Stockholder Equity280,205,508,085.11
LogoNovartis AG - Total Stockholder Equity255,096,620,580.91